MX2012003990A - Nanoparticulas fotoactivadas para dirigirse a células y tejidos. - Google Patents

Nanoparticulas fotoactivadas para dirigirse a células y tejidos.

Info

Publication number
MX2012003990A
MX2012003990A MX2012003990A MX2012003990A MX2012003990A MX 2012003990 A MX2012003990 A MX 2012003990A MX 2012003990 A MX2012003990 A MX 2012003990A MX 2012003990 A MX2012003990 A MX 2012003990A MX 2012003990 A MX2012003990 A MX 2012003990A
Authority
MX
Mexico
Prior art keywords
ligand
further characterized
particles
photo
composition according
Prior art date
Application number
MX2012003990A
Other languages
English (en)
Spanish (es)
Inventor
Robert S Langer
Tal Dvir
Daniel S Kohane
Matthew Ryan Banghart
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Publication of MX2012003990A publication Critical patent/MX2012003990A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0042—Photocleavage of drugs in vivo, e.g. cleavage of photolabile linkers in vivo by UV radiation for releasing the pharmacologically-active agent from the administered agent; photothrombosis or photoocclusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
    • A61K47/6929—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle
    • A61K47/6931—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle the material constituting the nanoparticle being a polymer
    • A61K47/6935—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle the material constituting the nanoparticle being a polymer the polymer being obtained otherwise than by reactions involving carbon to carbon unsaturated bonds, e.g. polyesters, polyamides or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MX2012003990A 2009-09-30 2010-09-30 Nanoparticulas fotoactivadas para dirigirse a células y tejidos. MX2012003990A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24753509P 2009-09-30 2009-09-30
PCT/US2010/050846 WO2011041496A1 (en) 2009-09-30 2010-09-30 Phototriggered nanoparticles for cell and tissue targeting

Publications (1)

Publication Number Publication Date
MX2012003990A true MX2012003990A (es) 2012-06-27

Family

ID=43826645

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012003990A MX2012003990A (es) 2009-09-30 2010-09-30 Nanoparticulas fotoactivadas para dirigirse a células y tejidos.

Country Status (12)

Country Link
US (1) US20130004522A1 (enExample)
EP (1) EP2482922A1 (enExample)
KR (1) KR20120080615A (enExample)
CN (1) CN102883773A (enExample)
AU (1) AU2010300629A1 (enExample)
BR (1) BR112012009182A2 (enExample)
CA (1) CA2780137C (enExample)
IL (1) IL218964A0 (enExample)
IN (1) IN2012DN03178A (enExample)
MX (1) MX2012003990A (enExample)
RU (1) RU2012117418A (enExample)
WO (1) WO2011041496A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2377781C2 (ru) 2003-07-17 2010-01-10 Юнилевер Н.В. Способ приготовления пищевой дисперсии, содержащей масло и структурирующий агент
AU2006215828B2 (en) 2005-02-17 2010-03-25 Unilever Plc Granules comprising sterol
WO2010033200A2 (en) 2008-09-19 2010-03-25 President And Fellows Of Harvard College Creation of libraries of droplets and related species
MX2011006423A (es) 2008-12-19 2011-07-20 Unilever Nv Polvos de grasas comestibles.
BR112012030147A2 (pt) 2010-06-22 2015-09-08 Unilever Nv "pó de gordura comestível, utilização do pó de gordura e processo para a preparação de um pó de gordura cometível
PL2651234T3 (pl) 2010-12-17 2015-06-30 Unilever Bcs Europe Bv Sposób kompaktowania mikroporowatego tłuszczowego proszku oraz tak otrzymany skompaktowany tłuszczowy proszek
PL2651229T3 (pl) 2010-12-17 2015-08-31 Unilever Bcs Europe Bv Jadalna emulsja typu woda w oleju
EP3065712A4 (en) 2013-11-08 2017-06-21 President and Fellows of Harvard College Microparticles, methods for their preparation and use
CN103623417B (zh) * 2013-12-18 2016-01-20 东华大学 一种功能化聚酰胺-胺树状大分子的纳米复合物的应用
CA3001679A1 (en) 2015-10-13 2017-04-20 President And Fellows Of Harvard College Systems and methods for making and using gel microspheres
JP7297065B2 (ja) * 2019-07-01 2023-06-23 富士フイルム株式会社 イメージセンサ
KR20210149956A (ko) * 2020-06-02 2021-12-10 삼성디스플레이 주식회사 양자점 조성물, 발광 소자 및 이의 제조 방법
CN114574187B (zh) * 2020-11-30 2024-03-05 北京京东方技术开发有限公司 纳米粒子、纳米粒子层图案化的方法及相关应用
CN115088088A (zh) * 2020-12-25 2022-09-20 京东方科技集团股份有限公司 量子点材料、发光器件及其制作方法、显示装置
US12187935B1 (en) * 2023-12-12 2025-01-07 Applied Materials, Inc. Liquid dispersion of quantum dots in an acrylic monomer medium

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998580A (en) * 1995-10-13 1999-12-07 Fay; Frederick F. Photosensitive caged macromolecules
US20070041934A1 (en) * 2005-08-12 2007-02-22 Regents Of The University Of Michigan Dendrimer based compositions and methods of using the same
WO2008109161A2 (en) * 2007-03-07 2008-09-12 The Albert Einstein College Of Medicine Of Yeshiva University Deeply quenched enzyme sensors

Also Published As

Publication number Publication date
WO2011041496A1 (en) 2011-04-07
IL218964A0 (en) 2012-06-28
US20130004522A1 (en) 2013-01-03
AU2010300629A1 (en) 2012-06-21
KR20120080615A (ko) 2012-07-17
BR112012009182A2 (pt) 2018-03-20
EP2482922A1 (en) 2012-08-08
CN102883773A (zh) 2013-01-16
CA2780137C (en) 2014-07-22
CA2780137A1 (en) 2011-04-07
IN2012DN03178A (enExample) 2015-09-25
RU2012117418A (ru) 2013-11-10

Similar Documents

Publication Publication Date Title
CA2780137C (en) Phototriggered nanoparticles for cell and tissue targeting
Li et al. Near-infrared light-triggered release of small molecules for controlled differentiation and long-term tracking of stem cells in vivo using upconversion nanoparticles
Jin et al. Theranostics of triple-negative breast cancer based on conjugated polymer nanoparticles
TWI741064B (zh) 用於修飾介導生物活性或與生物活性有關之靶結構之醫藥組合物及套組
Svenskaya et al. Photodynamic therapy platform based on localized delivery of photosensitizer by vaterite submicron particles
Neves-Petersen et al. UV light effects on proteins: from photochemistry to nanomedicine
TW200946164A (en) Methods and systems for treating cell proliferation disorders using plasmonics enhanced photospectral therapy (PEPST) and exciton-plasmon enhanced phototherapy (EPEP)
Li et al. Cancer cell membrane biomimetic nanosystem for homologous targeted dual-mode imaging and combined therapy
Shah The nanomaterial toolkit for neuroengineering
US20100075899A1 (en) Targeted photodynamic therapy agent
JP2022525791A (ja) 光免疫療法およびそれに用いる薬剤
WO2008121349A1 (en) Tag and target delivery system
CN103990124A (zh) 一种用于多模态成像/光动力治疗的石墨烯纳米复合粒子及其制备方法和用途
US10183081B2 (en) Use of scintillator-based nanoparticles for in vivo control of light-sensitive bioactive molecules
Dey et al. Challenges, conclusions, and future aspects of photodynamic therapy
CN119587504B (zh) 一种靶向骨组织巨噬细胞的纳米颗粒及其制备方法与应用
WO2013001451A1 (en) Vector for the release of an active agent which is photocleavable by irradiation in the visible
Giannini et al. Mesenchymal stem cells as delivery vehicle of porphyrin loaded nanoparticles: 2 Effective photoinduced in vitro killing of osteosarcoma
HK1004110B (en) Transfer of molecules into the cytosol of cells
HK1004110A1 (en) Transfer of molecules into the cytosol of cells

Legal Events

Date Code Title Description
FA Abandonment or withdrawal